Spectrum Pharmaceuticals reported $12.86M in Stock for its fiscal quarter ending in March of 2023.



Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Astellas Pharma JPY 297.26B 9.92B Mar/2025
AstraZeneca USD 6.57B 13M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
Biogen USD 1.95B 219.1M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 14.53B 785M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Incyte USD 115.62M 14.56M Mar/2026
J&J USD 14.58B 392M Mar/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Merck USD 6.48B 179M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Takeda JPY 1.41T 107.71B Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
TG Therapeutics USD 129.03M 3.44M Mar/2026